MKI67 and neoplasm: TAS102 treatment effectively reduced tumour burden and metastasis, particularly in TYMP-overexpressing ID8Luc mice, as evidenced by lower luciferin intensity and Ki67 staining (Fig. 6i–k, Fig. S6j).